While CB1 dominates the brain, CB2 receptors concentrate in immune cells and peripheral tissues, modulating inflammation. CB2 is the main reason researchers believe cannabinoids could have anti-inflammatory effects without a high.
What "strong evidence" means here: Convergent evidence: controlled trials, systematic reviews, or long-established pharmacology.